We are live on ! Find out more
MAU

MRA Associates USA Portfolio holdings

AUM $25.4M
1-Year Est. Return 0.38%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+0.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$56.2M
AUM Growth
-$9.69M
Cap. Flow
-$15M
Cap. Flow %
-26.7%
Top 10 Hldgs %
83.21%
Holding
78
New
9
Increased
27
Reduced
6
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGK icon
76
Vanguard FTSE Europe ETF
VGK
$30.1B
-1
Closed
VOE icon
77
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
-340
Closed -$32K
VXUS icon
78
Vanguard Total International Stock ETF
VXUS
$162B
-2
Closed

Similar funds

MRA Associates USA's Q1 2019 Portfolio in Review

As of Q1 2019, MRA Associates USA held 78 positions worth $56.2M, down 15% from $65.9M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

MRA Associates USA withdrew a net $15M in Q1 2019, closing 7 positions and reducing 6 holdings. Its most notable exit was Vanguard Short-Term Bond ETF, an estimated $3.93M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 61% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, MRA Associates USA opened a new position in iShares Russell Mid-Cap Growth ETF worth $190K.

  • MRA Associates USA's largest Q1 2019 buy was iShares Russell Mid-Cap Growth ETF: 2,804 shares worth $190K.
  • MRA Associates USA added most to Vanguard Morningstar Total Stock Market ETF in Q1 2019, an estimated $383K increase.
  • MRA Associates USA's biggest Q1 2019 reduction was Golub Capital BDC, cutting an estimated $5.54M.
  • MRA Associates USA fully exited Vanguard Short-Term Bond ETF in Q1 2019, selling an estimated $3.93M.
  • MRA Associates USA's ten largest holdings make up 83% of its $56.2M portfolio in Q1 2019.
  • MRA Associates USA opened 9 new positions and closed 7 in Q1 2019.
  • MRA Associates USA's portfolio value fell 15% quarter-over-quarter to $56.2M.

Based on MRA Associates USA's 13F filing for Q1 2019, filed 15 May 2019.